ArticleIJU case reports2025

Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases.

Daisuke Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.